Review
doi: 10.1093/infdis/jiz134.
Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges
Affiliations
- PMID: 30893436
- DOI: 10.1093/infdis/jiz134
Item in Clipboard
Review
Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges
J Infect Dis.
.
Free article
Abstract
This review presents potential benefits and limitations of innovative strategies that are currently investigated for the discovery of novel antibacterial agents to prevent or treat infections caused by multidrug-resistant organisms.
Keywords: antibacterials; antimicrobial resistance; multidrug resistance; therapeutic alternatives.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Similar articles
-
Where are we with monoclonal antibodies for multidrug-resistant infections?Drug Discov Today. 2019 May;24(5):1132-1138. doi: 10.1016/j.drudis.2019.03.002. Epub 2019 Mar 8. Drug Discov Today. 2019. PMID: 30853568 Review.
-
Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview.Microb Drug Resist. 2019 Jul/Aug;25(6):890-908. doi: 10.1089/mdr.2018.0319. Epub 2019 Feb 27. Microb Drug Resist. 2019. PMID: 30811275 Review.
-
Antibacterial drug development: challenges, recent developments, and future considerations.Clin Pharmacol Ther. 2014 Aug;96(2):147-9. doi: 10.1038/clpt.2014.116. Clin Pharmacol Ther. 2014. PMID: 25056394 Review.
-
Current challenges in the discovery of novel antibacterials from microbial natural products.Recent Pat Antiinfect Drug Discov. 2012 Dec 1;7(3):189-204. doi: 10.2174/157489112803521968. Recent Pat Antiinfect Drug Discov. 2012. PMID: 22963258 Review.
-
Discovery and development of new antibacterial agents targeting Gram-negative bacteria in the era of pandrug resistance: is the future promising?Curr Opin Pharmacol. 2014 Oct;18:91-7. doi: 10.1016/j.coph.2014.09.008. Epub 2014 Sep 29. Curr Opin Pharmacol. 2014. PMID: 25277839 Review.
Cited by
-
Linearized esculentin-2EM shows pH dependent antibacterial activity with an alkaline optimum.Mol Cell Biochem. 2021 Oct;476(10):3729-3744. doi: 10.1007/s11010-021-04181-7. Epub 2021 Jun 6. Mol Cell Biochem. 2021. PMID: 34091807 Free PMC article.
-
Identification and Validation of a Novel Antibacterial Compound MZ-01 against Methicillin-Resistant Staphylococcus aureus.Antibiotics (Basel). 2022 Nov 4;11(11):1550. doi: 10.3390/antibiotics11111550. Antibiotics (Basel). 2022. PMID: 36358205 Free PMC article.
-
Health horizons: Future trends and technologies from the European Medicines Agency's horizon scanning collaborations.Front Med (Lausanne). 2022 Dec 8;9:1064003. doi: 10.3389/fmed.2022.1064003. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36569125 Free PMC article.
-
Nanomaterials as Delivery Vehicles and Components of New Strategies to Combat Bacterial Infections: Advantages and Limitations.Microorganisms. 2019 Sep 16;7(9):356. doi: 10.3390/microorganisms7090356. Microorganisms. 2019. PMID: 31527443 Free PMC article. Review.
-
Emerging Prospects of Nanozymes for Antibacterial and Anticancer Applications.Biomedicines. 2022 Jun 10;10(6):1378. doi: 10.3390/biomedicines10061378. Biomedicines. 2022. PMID: 35740402 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
